Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.39−0.03 (-0.39%)
Close on Nov 17, 2026Market cap $241.88MP/E –Yield –
Lifecore Biomedical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Lifecore Biomedical's operating cash flow for the twelve months ending May 25, 2025 was -$206.00K, down 180.2% year over year. For fiscal 2025 it was -$206.00K, down 180.2% from the year before. The highest annual figure on record is $29.84M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 25, 2025 | -$206.00K | -180.2% |
| FY2024 | May 26, 2024 | $257.00K | – |
| FY2023 | May 28, 2023 | -$17.44M | – |
| FY2022 | May 29, 2022 | -$22.59M | -237.2% |
| FY2021 | May 30, 2021 | $16.47M | – |
| FY2020 | May 31, 2020 | -$17.04M | -206.4% |
| FY2019 | May 26, 2019 | $16.02M | -19.0% |
| FY2018 | May 27, 2018 | $19.78M | -33.7% |
| FY2017 | May 28, 2017 | $29.84M | +43.7% |
| FY2016 | May 29, 2016 | $20.76M | -22.0% |
| FY2015 | May 31, 2015 | $26.62M | +26.5% |
| FY2014 | May 25, 2014 | $21.05M | -0.9% |
| FY2013 | May 26, 2013 | $21.23M | -4.3% |
| FY2012 | May 27, 2012 | $22.18M | +53.3% |
| FY2011 | May 29, 2011 | $14.47M | +93.4% |
| FY2010 | May 30, 2010 | $7.48M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | May 25, 2025 | $5.35M | -38.7% |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | $1.20M | – |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | -$6.14M | -576.7% |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | -$613.00K | – |
| Q4 FY2024CQ2 2024 | May 26, 2024 | $8.72M | – |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | -$1.42M | – |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | $1.29M | – |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | -$8.33M | – |
| Q4 FY2023CQ2 2023 | May 28, 2023 | -$2.26M | – |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | -$11.73M | – |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | -$2.35M | – |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | -$1.10M | -179.8% |
| Q4 FY2022CQ2 2022 | May 29, 2022 | -$1.85M | -136.4% |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | -$17.31M | – |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | -$4.81M | -491.1% |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | $1.38M | -92.0% |
| Q4 FY2021CQ2 2021 | May 30, 2021 | $5.09M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$7.07M | -166.8% |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | $1.23M | – |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | $17.23M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$12.70M | – |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | $10.58M | -16.3% |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | -$9.48M | -462.4% |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | -$5.44M | -348.8% |
| Q4 FY2019CQ2 2019 | May 26, 2019 | -$1.43M | – |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | $12.65M | -37.7% |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | $2.62M | -58.7% |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | $2.19M | -36.6% |
| Q4 FY2018CQ2 2018 | May 27, 2018 | -$521.00K | -107.8% |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | $20.30M | -23.8% |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | $6.34M | -34.8% |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | $3.45M | -65.4% |
| Q4 FY2017CQ2 2017 | May 28, 2017 | $6.66M | -53.6% |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | $26.63M | +541.9% |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | $9.71M | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | $9.97M | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | $14.33M | – |
| Q3 FY2016CQ1 2016 | Feb 28, 2016 | $4.15M | – |
See a number that looks wrong?